EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Increased cardiovascular morbidity and reduced life expectancy in a large Italian cohort of patients with resistance to thyroid hormone β (RTHβ)

Irene Campi iD, Simona Censi, Flavia Prodam iD, Luisa Petrone iD, Giulia Brigante iD, Tommaso Porcelli, Rosaria Maddalena Ruggeri, Maria Cristina Vigone, Giuditta Rurale, Serafino Lio, Carla Pelusi, Luca Persani iD

European Journal of Endocrinology · 2024

DOI: 10.1093/ejendo/lvae117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Irene Campi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, 20100 Milan, Italy. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Life Expectancy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Italian Ministry of Health-Ricerca Corrente, Italian Ministry of Health—Ricerca Corrente.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Decreased survival and higher cardiovascular morbidity have been recently reported in a UK cohort of 61 RTHβ patients, but there is no evidence from other countries.

Design

Retrospective cohort study from an historical group of 284 Italian RTHβ patients, diagnosed between 1984 and 2023.

Methods

We collected data on diagnosis of 284 cases and longitudinal data of 249 RTHβ who carried heterozygous pathogenic variants in the THRB gene. We studied how thyroid function and recognized risk factors for cardiovascular disease, such as hypertension and diabetes, affected overall mortality and major cardiovascular events.

Results

The cumulative prevalence of sinus/supraventricular tachycardia and atrial fibrillation was 40% and 18%, respectively. FT4 values 57% higher than the upper limit of normal were associated with premature cardiovascular manifestations. Major cardiovascular events (MACEs) occurred in RTHβ patients at a median age (IQR) of 59.4 years (50.4-66.4) and early mortality resulted in a mean of 11 years of life lost. While at univariable analysis hypertension, dyslipidemia, high fasting glucose/diabetes were also associated with MACEs, at multivariable analysis only age at diagnosis, increased fT4 levels, and male gender remained significantly associated with MACEs and age at diagnosis and higher fT4 levels with mortality. Previous thyroidectomy or radioiodine therapy had no statistically significant effect in the prevention of major cardiovascular events or all-cause mortality.

Conclusions

These data should raise the general awareness on the cardiovascular risk and prompt a proactive cardiovascular monitoring in RTHβ, especially in men and those with fT4 levels above 30 pmol/L.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesLife ExpectancyHumansMaleFemaleMiddle AgedItalyRetrospective StudiesAgedThyroid Hormone Resistance SyndromeCohort StudiesAdultThyroid Hormone Receptors betaRisk FactorsMorbidity

Stichwörter der Autor:innen

RTHβatrial fibrillationcentral hyperthyroidismmajor cardiovascular eventsmortality

Substanzen

Thyroid Hormone Receptors beta

Autor:innen und Institutionen

  • Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano, 20100 Milan, Italy.
  • Endocrinology Unit, Department of Medicine (DIMED), University of Padua, 35121 Padua, Italy.
  • Unit of Endocrinology; Department of Health Sciences, University of Piemonte Orientale, 28100 Novara, Italy.
  • Endocrinology Unit, Medical-Geriatric Department, Careggi University Hospital, 50134 Florence, Italy.
  • Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
  • Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.

ORCID-Profile: Irene Campi, Flavia Prodam, Luisa Petrone, Giulia Brigante, Luca Persani

Förderung

  • Italian Ministry of Health-Ricerca Corrente
  • Italian Ministry of Health—Ricerca Corrente

Zitieren

APA

Campi, I., Censi, S., Prodam, F., Petrone, L., Brigante, G., Porcelli, T., Ruggeri, R. M., Vigone, M. C., Rurale, G., Lio, S., Pelusi, C., & Persani, L. (2024). Increased cardiovascular morbidity and reduced life expectancy in a large Italian cohort of patients with resistance to thyroid hormone β (RTHβ). European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae117

Vancouver

Campi I, Censi S, Prodam F, Petrone L, Brigante G, Porcelli T, et al. Increased cardiovascular morbidity and reduced life expectancy in a large Italian cohort of patients with resistance to thyroid hormone β (RTHβ). European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae117

BibTeX
@article{Campi2024,
  author = {Campi, Irene and Censi, Simona and Prodam, Flavia and Petrone, Luisa and Brigante, Giulia and Porcelli, Tommaso and Ruggeri, Rosaria Maddalena and Vigone, Maria Cristina and Rurale, Giuditta and Lio, Serafino and Pelusi, Carla and Persani, Luca},
  title = {Increased cardiovascular morbidity and reduced life expectancy in a large Italian cohort of patients with resistance to thyroid hormone β (RTHβ)},
  journal = {European Journal of Endocrinology},
  year = {2024},
  doi = {10.1093/ejendo/lvae117}
}
Kostenlos starten →